Fozal
Formulation
Each modified-release tablet contains:
Alfuzosin Hydrochloride 500 mg

Alfuzosin Hydrochloride

Fozal®

Prescription Drug

Indication

  • For the treatment of signs and symptoms of benign prostatic hyperplasia (BPH)
  • As an adjunct therapy with urethral catheterization for Acute Urinary Retention related to BPH and management following catheter removal

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Insert.

Please consult your physician and other healthcare providers before taking any prescription medicines found on this site. The contents found on this page are for information purposes only. It should not be construed as a substitute for professional medical advise and should not be relied upon in that regard. You undertake to carefully read all product packaging and labels prior to use.

Caution: Food, Drugs, Devices and Cosmetics Act prohibits dispensing without prescription.